1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Ham: new trials by email Literature Review of Ham trials Research Report on Ham
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy Study for Patients With Stage IV Melanoma HyperAcute®-Melanoma (HAM) Immunotherapy, Ipilimumab, Pembrolizumab - Stage IV Melanoma, Metastatic Melanoma | Phase 2 | Terminated | NewLink Genetics Corporation | 47 | 2014-06-01 | 2023-04-18 |
Melanoma (1)
NewLink Genetics Corporation (1)
United States (1)